Completed NA INTERVENTIONAL 2-arm NCT03155269

To Investigate the Impact of a Nutritional Supplement on Bone Turnover Markers in Indian Healthy Premenopausal Women (25- 45 Years) After 6 Months of Intervention

Impact of a Nutritional Supplement on Bone Turnover Markers in Indian Healthy Premenopausal Women (25-45 Yrs; Inclusive) After 6 Months of Intervention: a Randomised Double Blind Controlled Trial

Sponsor: GlaxoSmithKline

Conditions Growth and Development

Interventions Fortified Beverage Powder Non fortified beverage Powder

Updated 8 times since 2017 Last updated: Jan 15, 2019 Started: May 25, 2017 Primary completion: Jan 16, 2018 Completion: Jan 16, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Growth and Development, this trial is completed. The trial is conducted by GlaxoSmithKline and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
May 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — May 2019 [monthly]

Completed NA

▶ Show 3 earlier versions

Feb 2018 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Aug 2017 — Feb 2018 [monthly]

Recruiting NA
Jun 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pune, India